Evidence map›Paper›PMID 36009556›Full record

ArticleBiomedicines2022

Cocoa Extract Provides Protection against 6-OHDA Toxicity in SH-SY5Y Dopaminergic Neurons by Targeting PERK.

Vincenzo Vestuto, Giuseppina Amodio, Giacomo Pepe, Manuela Giovanna Basilicata, Raffaella Belvedere, Enza Napolitano, Daniela Guarnieri, Valentina Pagliara, Simona Paladino, Manuela Rodriquez and 4 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Anticancer Therapies Based on Oxidative Damage:Antioxidants (Basel, Switzerland) · 2024
    Article
  8. Antitumor Mechanisms ofLife (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Plants (Basel, Switzerland) · 2023
    Article
  15. New Frontiers on ER Stress Modulation: Are TRP Channels the Leading Actors?International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Vincenzo VestutoDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.ORCID 0000-0002-3603-5526
Giuseppina AmodioDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, I-84034 Baronissi-Salerno, Italy.
Giacomo PepeDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.
Manuela Giovanna BasilicataDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.
Raffaella BelvedereDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.ORCID 0000-0002-5036-7869
Enza NapolitanoDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.
Daniela GuarnieriDepartment of Chemistry and Biology, I-84034 Fisciano-Salerno, Italy.
Valentina PagliaraDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, I-84034 Baronissi-Salerno, Italy.ORCID 0000-0001-9320-6080
Simona PaladinoDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, I-80131 Naples, Italy.ORCID 0000-0001-5332-6774
Manuela RodriquezDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.ORCID 0000-0002-4412-238X
Alessia BertaminoDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.
Pietro CampigliaDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.ORCID 0000-0002-1069-2181
Paolo RemondelliDepartment of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, I-84034 Baronissi-Salerno, Italy.ORCID 0000-0002-3698-3497
Ornella MoltedoDepartment of Pharmacy, University of Salerno, I-84034 Fisciano-Salerno, Italy.ORCID 0000-0002-0526-2152
University of Salerno · ITUniversity of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) represents one of the most common neurodegenerative disorders, characterized by a dopamine (DA) deficiency in striatal synapses and misfolded toxic α-synuclein aggregates with concomitant cytotoxicity. In this regard, the misfolded proteins accumulation in neurodegenerative disorders induces a remarkable perturbations of endoplasmic reticulum (ER) homeostasis leading to persistent ER stress, which in turn, effects protein synthesis, modification, and folding quality control. A large body of evidence suggests that natural products target the ER stress signaling pathway, exerting a potential action in cancers, diabetes, cardiovascular and neurodegenerative diseases. This study aims to assess the neuroprotective effect of cocoa extract and its purified fractions against a cellular model of Parkinson's disease represented by 6-hydroxydopamine (6-OHDA)-induced SH-SY5Y human neuroblastoma. Our findings demonstrate, for the first time, the ability of cocoa to specifically targets PERK sensor, with significant antioxidant and antiapoptotic activities as both crude and fractioning extracts. In addition, cocoa also showed antiapoptotic properties in 3D cell model and a notable ability to inhibit the accumulation of α-synuclein in 6-OHDA-induced cells. Overall, these results indicate that cocoa exerts neuroprotective effects suggesting a novel possible strategy to prevent or, at least, mitigate neurodegenerative disorders, such as PD.

Indexed as

cocoaendoplasmic reticulum stressoxidative stressParkinson’s diseasePERKunfolded protein response

Identifiers

PMID36009556
PMCPMC9405838
OpenAlexW4293514278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.